<p>HDAC1/2 Inhibitor Romidepsin Suppresses DEN-Induced Hepatocellular Carcinogenesis in Mice</p>-Reference-Cited by-同舟云学术

HDAC1/2 Inhibitor Romidepsin Suppresses DEN-Induced Hepatocellular Carcinogenesis in Mice

Published:2020-06 Issue: Volume:Volume 13 Page:5575-5588
ISSN:1178-6930
Container-title:OncoTargets and Therapy
language:en
Short-container-title:OTT

Author:

Afaloniati Hara^ORCID,Angelopoulou Katerina^ORCID,Giakoustidis Alexander,Hardas Alexandros^ORCID,Pseftogas Athanasios^ORCID,Makedou Kali^ORCID,Gargavanis Athanasios^ORCID,Goulopoulos Thomas,Iliadis Stavros,Papadopoulos Vasileios,Papalois Apostolos,Mosialos George,Poutahidis Theofilos^ORCID,Giakoustidis Dimitrios

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Reference71 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. The evolving epidemiology of hepatocellular carcinoma: a global perspective

3. Multistep human hepatocarcinogenesis: correlation of imaging with pathology

4. Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting SMAD-Dependent Signaling: Considerations in Epithelial and Mesenchymal Solid Tumors;Pharmaceuticals;2024-03-01

2. Pyroptosis Tuning in Intestinal Cryptosporidiosis via the Natural Histone Deacetylase Inhibitor Romidepsin;Parasite Immunology;2024-03

3. The epigenetic factor CHD4 contributes to metastasis by regulating the EZH2/β-catenin axis and acts as a therapeutic target in ovarian cancer;Journal of Translational Medicine;2023-01-21

4. HDAC11, an emerging therapeutic target for metabolic disorders;Frontiers in Endocrinology;2022-10-20

5. Profiles of Acetylation Regulation Genes Contribute to Malignant Progression and Have a Clinical Prognostic Impact on Liver Cancer;Disease Markers;2022-09-10